Literature DB >> 22224191

Infection Associated with Hemophagocytic Lymphohisticytosis triggered by nosocomial Infection.

J B Gosh, Mahua Roy, Ashok Bala.   

Abstract

Hemophagocytic lymphohistiocytosis (HLH) can occur as primary idiopathic syndrome or secondary to neoplastic, infection or autoimmune processes. It is characterized by the proliferation of histiocytes with phagocytosis of formed elements of blood. Clinical manifestations include signs and symptoms of immune activation and pancytopenia. This report presents a child with infection associated with HLH trigged by Acinetobacter baumannii sepsis. Multidrug-resistant Acinetobacter, an emergent nosocomial pathogen but so far in the literature, it has not been reported to cause HLH.

Entities:  

Year:  2009        PMID: 22224191      PMCID: PMC3251180          DOI: 10.5001/omj.2009.45

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  10 in total

1.  Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society.

Authors:  J I Henter; G Elinder; A Ost
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

Review 2.  Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.

Authors:  B E Favara; A C Feller; M Pauli; E S Jaffe; L M Weiss; M Arico; P Bucsky; R M Egeler; G Elinder; H Gadner; M Gresik; J I Henter; S Imashuku; G Janka-Schaub; R Jaffe; S Ladisch; C Nezelof; J Pritchard
Journal:  Med Pediatr Oncol       Date:  1997-09

Review 3.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 4.  Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis.

Authors:  G Janka; S Imashuku; G Elinder; M Schneider; J I Henter
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

Review 5.  Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; M Aricò; G Elinder; S Imashuku; G Janka
Journal:  Hematol Oncol Clin North Am       Date:  1998-04       Impact factor: 3.722

6.  Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis.

Authors:  J I Henter; G Elinder; O Söder; A Ost
Journal:  Acta Paediatr Scand       Date:  1991-04

7.  Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: clinical features, molecular epidemiology, and antimicrobial susceptibility.

Authors:  H Wisplinghoff; M B Edmond; M A Pfaller; R N Jones; R P Wenzel; H Seifert
Journal:  Clin Infect Dis       Date:  2000-10-04       Impact factor: 9.079

8.  Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a university hospital in Taiwan.

Authors:  Lu-Cheng Kuo; Lee-Jene Teng; Chong-Jen Yu; Shen-Wu Ho; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii.

Authors:  Carl Urban; Sorana Segal-Maurer; James J Rahal
Journal:  Clin Infect Dis       Date:  2003-05-01       Impact factor: 9.079

Review 10.  Hemophagocytic syndromes and infection.

Authors:  D N Fisman
Journal:  Emerg Infect Dis       Date:  2000 Nov-Dec       Impact factor: 6.883

  10 in total
  2 in total

1.  Hemophagocytic Lymphohistiocytosis in the Setting of Therapy-Induced Acute Myeloid Leukemia: An Autopsy Report.

Authors:  Hisham F Bahmad; Samantha Gogola; Mohamad K Elajami; Carole Brathwaite; Amilcar A Castellano-Sánchez; Vathany Sriganeshan; Yumna Omarzai
Journal:  Diseases       Date:  2022-08-19

Review 2.  Debate around infection-dependent hemophagocytic syndrome in paediatrics.

Authors:  Valentina Ansuini; Donato Rigante; Susanna Esposito
Journal:  BMC Infect Dis       Date:  2013-01-16       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.